Hypertension, Vol 10, 249-253, Copyright © 1987 by American Heart Association
DE Uehlinger, T Zaman, P Weidmann, S Shaw and MP Gnadinger
The relative contribution of increased blood pressure (BP) or
norepinephrine (NE), or both, to the stimulatory effect of an NE pressor
infusion on circulating immunoreactive atrial natriuretic peptide (ANP) was
evaluated in 10 healthy young men. They were studied during an infusion of
NE, which was applied initially alone and then in combination with sodium
nitroprusside. NE infusion rate was increased in four 30-minute intervals
to a final dose of 200 ng/kg body weight per minute, leading to 12-fold
higher plasma NE levels than were seen during control conditions. This
increased mean BP (from a mean basal value of 94 +/- 3 to 119 +/- 4 [SEM]
mm Hg; p less than 0.001) and plasma immunoreactive ANP (from 50 +/- 7 to
112 +/- 17 pg/ml; p less than 0.001), whereas heart rate decreased (p less
than 0.001). The NE infusion was continued at the highest dose and an
additional infusion of sodium nitroprusside was started to titrate mean BP
in 30-minute intervals down to control values; a mean sodium nitroprusside
dose of 0.95 micrograms/kg/min restored mean BP to 93 +/- 4 mm Hg (p less
than 0.001), decreased plasma immunoreactive ANP to basal values (51 +/- 4
pg/ml; p less than 0.001), increased heart rate (p less than 0.001), and
left plasma levels of NE largely unchanged. Plasma protein and hematocrit
rose about 5 to 6% (p less than 0.001) during the NE infusion and then
decreased about 3 to 4% (p less than 0.001 and p less than 0.01) when
sodium nitroprusside was added.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Pressure dependence of atrial natriuretic peptide during norepinephrine infusion in humans
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |